VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
THALL, PETER F
One or more keywords matched the following items that are connected to
THALL, PETER F
Item Type
Name
Concept
Computer Simulation
Academic Article
Accrual strategies for phase I trials with delayed patient outcome.
Academic Article
Practical model-based dose-finding in phase I clinical trials: methods based on toxicity.
Academic Article
Monitoring event times in early phase clinical trials: some practical issues.
Academic Article
Adaptive dose selection using efficacy-toxicity trade-offs: illustrations and practical considerations.
Academic Article
Simultaneously optimizing dose and schedule of a new cytotoxic agent.
Academic Article
Bayesian adaptive model selection for optimizing group sequential clinical trials.
Academic Article
Practical model-based dose finding in early-phase clinical trials: optimizing tissue plasminogen activator dose for treatment of ischemic stroke in children.
Academic Article
Evaluating multiple treatment courses in clinical trials.
Academic Article
Monitoring the rates of composite events with censored data in phase II clinical trials.
Academic Article
Continuous Bayesian adaptive randomization based on event times with covariates.
Academic Article
Bayesian designs to account for patient heterogeneity in phase II clinical trials.
Academic Article
Utility-based optimization of combination therapy using ordinal toxicity and efficacy in phase I/II trials.
Academic Article
Using joint utilities of the times to response and toxicity to adaptively optimize schedule-dose regimes.
Academic Article
Determining a maximum-tolerated schedule of a cytotoxic agent.
Academic Article
Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.
Academic Article
Optimization of multi-stage dynamic treatment regimes utilizing accumulated data.
Academic Article
A simulation study of methods for selecting subgroup-specific doses in phase 1 trials.
Academic Article
A simulation study of outcome adaptive randomization in multi-arm clinical trials.
Academic Article
A utility-based design for randomized comparative trials with ordinal outcomes and prognostic subgroups.
Academic Article
Phase I-II clinical trial design: a state-of-the-art paradigm for dose finding.
Academic Article
A hybrid phase I-II/III clinical trial design allowing dose re-optimization in phase III.
Academic Article
Bayesian variable selection based on clinical relevance weights in small sample studies-Application to colon cancer.
Academic Article
An adaptive trial design to optimize dose-schedule regimes with delayed outcomes.
Academic Article
Bayesian cancer clinical trial designs with subgroup-specific decisions.
Academic Article
Comparing Bayesian early stopping boundaries for phase II clinical trials.
Academic Article
Comparison of Phase I-II designs with parametric or semi-parametric models using two different risk-benefit trade-off criteria.
Academic Article
Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers.
Academic Article
Precision Bayesian phase I-II dose-finding based on utilities tailored to prognostic subgroups.
Academic Article
A Bayesian piecewise exponential phase II design for monitoring a time-to-event endpoint.
Academic Article
Bayesian treatment screening and selection using subgroup-specific utilities of response and toxicity.
Academic Article
Generalized phase I-II designs to increase long term therapeutic success rate.
Academic Article
BASIC: A Bayesian adaptive synthetic-control design for phase II clinical trials.
Academic Article
A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparison.
Search Criteria
Computer Simulation